BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 15694201)

  • 21. Demyelination in peroxisomal diseases.
    Powers JM
    J Neurol Sci; 2005 Feb; 228(2):206-7. PubMed ID: 15694208
    [No Abstract]   [Full Text] [Related]  

  • 22. [Development and regeneration of oligodendrocytes: therapeutic perspectives in demyelinating diseases].
    Dubois-Dalcq M
    Bull Mem Acad R Med Belg; 2005; 160(10-12):407-15; discussion 415-6. PubMed ID: 16768245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central nervous system myelin: structure, synthesis and assembly.
    Aggarwal S; Yurlova L; Simons M
    Trends Cell Biol; 2011 Oct; 21(10):585-93. PubMed ID: 21763137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic alterations in the mouse myelin basic proteins result in a range of dysmyelinating disorders.
    Jacobs EC
    J Neurol Sci; 2005 Feb; 228(2):195-7. PubMed ID: 15694204
    [No Abstract]   [Full Text] [Related]  

  • 25. Galactosphingolipids and axono-glial interaction in myelin of the central nervous system.
    Bosio A; Büssow H; Adam J; Stoffel W
    Cell Tissue Res; 1998 May; 292(2):199-210. PubMed ID: 9560463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uncoupling of neuroinflammation from axonal degeneration in mice lacking the myelin protein tetraspanin-2.
    de Monasterio-Schrader P; Patzig J; Möbius W; Barrette B; Wagner TL; Kusch K; Edgar JM; Brophy PJ; Werner HB
    Glia; 2013 Nov; 61(11):1832-47. PubMed ID: 24038504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Toxic nervous pathology: biochemistry of myelin and demyelinizing conditions].
    Baumann N
    Eur J Toxicol; 1972; 5(1):7-11. PubMed ID: 4647427
    [No Abstract]   [Full Text] [Related]  

  • 28. Myelin and disorders that affect the formation and maintenance of this sheath.
    Porter BE; Tennekoon G
    Ment Retard Dev Disabil Res Rev; 2000; 6(1):47-58. PubMed ID: 10899797
    [No Abstract]   [Full Text] [Related]  

  • 29. Disrupted compaction of CNS myelin in an OSP/Claudin-11 and PLP/DM20 double knockout mouse.
    Chow E; Mottahedeh J; Prins M; Ridder W; Nusinowitz S; Bronstein JM
    Mol Cell Neurosci; 2005 Jul; 29(3):405-13. PubMed ID: 15886014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axon degeneration mechanisms: commonality amid diversity.
    Coleman M
    Nat Rev Neurosci; 2005 Nov; 6(11):889-98. PubMed ID: 16224497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.
    Wang D; Ayers MM; Catmull DV; Hazelwood LJ; Bernard CC; Orian JM
    Glia; 2005 Aug; 51(3):235-40. PubMed ID: 15812814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic nerve compression induces local demyelination and remyelination in a rat model of carpal tunnel syndrome.
    Gupta R; Rowshan K; Chao T; Mozaffar T; Steward O
    Exp Neurol; 2004 Jun; 187(2):500-8. PubMed ID: 15144876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Factors that intervene in the process of myelinization of the central nervous system].
    Molinuevo ML; Rodríguez-Fernández C
    Rev Clin Esp; 1980 Jun; 157(6):377-9. PubMed ID: 7414028
    [No Abstract]   [Full Text] [Related]  

  • 34. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS.
    Filbin MT
    Nat Rev Neurosci; 2003 Sep; 4(9):703-13. PubMed ID: 12951563
    [No Abstract]   [Full Text] [Related]  

  • 35. Insulating axons via NF-kappaB.
    Mattson MP
    Nat Neurosci; 2003 Feb; 6(2):105-6. PubMed ID: 12555100
    [No Abstract]   [Full Text] [Related]  

  • 36. Myosin II has distinct functions in PNS and CNS myelin sheath formation.
    Wang H; Tewari A; Einheber S; Salzer JL; Melendez-Vasquez CV
    J Cell Biol; 2008 Sep; 182(6):1171-84. PubMed ID: 18794332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation.
    Garbern JY; Yool DA; Moore GJ; Wilds IB; Faulk MW; Klugmann M; Nave KA; Sistermans EA; van der Knaap MS; Bird TD; Shy ME; Kamholz JA; Griffiths IR
    Brain; 2002 Mar; 125(Pt 3):551-61. PubMed ID: 11872612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High resolution neurochemical gold staining method for myelin in peripheral and central nervous system at the light- and electron-microscopic level.
    Savaskan NE; Weinmann O; Heimrich B; Eyupoglu IY
    Cell Tissue Res; 2009 Aug; 337(2):213-21. PubMed ID: 19513756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remyelination of the central nervous system: a valuable contribution from the periphery.
    Zujovic V; Bachelin C; Baron-Van Evercooren A
    Neuroscientist; 2007 Aug; 13(4):383-91. PubMed ID: 17644768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Galectin-3/MAC-2, Ras and PI3K activate complement receptor-3 and scavenger receptor-AI/II mediated myelin phagocytosis in microglia.
    Rotshenker S; Reichert F; Gitik M; Haklai R; Elad-Sfadia G; Kloog Y
    Glia; 2008 Nov; 56(15):1607-13. PubMed ID: 18615637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.